26-12-2019 дата публикации
Номер: US20190388447A1
Принадлежит:
The present disclosure discloses simple and efficient glycan- or carbohydrate-based processes or methods for the rapid identification of biological markers and therapeutic targets especially glycan-related targets of infectious diseases, cancers, autoimmune diseases, allergies, inflammation, toxicity, obesity and/or other disorders of humans, animals, plants and other organisms. Therefore, novel methods and products for the diagnosis, prevention, and treatment of such diseases obtainable based on these therapeutic targets can be developed. 2: The method of claim 1 , wherein the pharmaceutical composition is in the form of a tablet claim 1 , a capsule claim 1 , a pill claim 1 , a powder claim 1 , or granules.3: The method of claim 1 , wherein the pharmaceutical composition is administered orally.4: The method of claim 1 , wherein the analog of N-acetylneuraminic acid is N-acetylneuraminic acid methyl ester.5: The method of claim 1 , wherein the analog of N-acetylneuraminic acid is a hydroxylated analog of N-acetylneuraminic acid claim 1 , a glycoconjugate of N-acetylneuraminic acid or an N-acetylneuraminic acid containing an O- or N-glycosidic linkage to an amino acid.6: The method of claim 1 , wherein administration of N-acetylneuraminic acid methyl ester treats or prevents viral diarrhea in the patient.7: The method of claim 1 , wherein administration of N-acetylneuraminic acid methyl ester treats or prevents an infectious disease caused by an influenza virus claim 1 , a Newcastle disease virus claim 1 , or a rotavirus in the patient. This application is a divisional of U.S. application Ser. No. 14/803,725, filed Jul. 20, 2015, which is a divisional of U.S. application Ser. No. 12/900,913, filed Oct. 8, 2010, now U.S. Pat. No. 9,119,866, issued Sep. 1, 2015, which claims the benefit of priority from U.S. Provisional Application No. 61/278,685, filed Oct. 9, 2009, and U.S. Provisional Application No. 61/335,415, filed Jan. 7, 2010, and which is a continuation-in- ...
Подробнее